Cluster buy at Orchestra BioMed Holdings, Inc.: five insiders add $6.23M of OBIO
Five insiders reported purchases totalling $6.23 million in Form 4 filings.
Form 4 filings show five Orchestra BioMed Holdings, Inc. insiders buying stock on Nov 9, for a total of $6.23 million.
Rtw Investments, LP (10% owner) made the largest purchase, $6 million at an average of $5.00 a share. Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy.
Every purchase was an open-market trade (transaction code P) of common stock, and none is marked as part of a 10b5-1 plan. The table below lists who bought, when, and at what price.
The numbers below are taken from the Form 4 as filed with the SEC.
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| Andrew Lawrence Taylor | CFO | Nov 9 | 1,000 | $5.00 | $5,000 | App · SEC |
| David P Hochman | Officer | Nov 9 | 5,000 | $5.00 | $25,000 | App · SEC |
| David Pacitti | Director | Nov 9 | 20,000 | $5.00 | $100,000 | App · SEC |
| Eric S Fain | Director | Nov 9 | 20,000 | $5.00 | $100,000 | App · SEC |
| Rtw Investments, LP | 10% owner | Nov 9 | 1,200,000 | $5.00 | $6,000,000 | App · SEC |
| Total | $6,230,000 | |||||
See the full OBIO insider activity report
Each row of the table links to its Form 4 on SEC.gov.
Browse the latest insider buying · Read the daily insider trading roundup
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.